Table 6. Regression analyses of DCR in the XELOX group.

DCR	Coef.	Std. Err.	t	P	95% CI
Study type	0.0055461	0.0924147	0.06	0.962	–1.168694 to 1.179786
Gender	1.428532	0.4492353	3.18	0.194	–4.279555 to 7.136596
_cons	0.1183735	0.3428134	–0.35	0.788	–4.475501 to 4.238754

DCR, disease control rate; XELOX, oxaliplatin combined with capecitabine; Coef., coefficient; Std. Err., standard error; CI, confidence interval.